FISCHERFischer Medical Ventures Limited
Healthcare · Medical Devices · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on FISCHER — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why avoid
- • Risk gate: safety score is only 30/100 — volatility, drawdown or liquidity is too poor for a buy call, whatever the chart says
- • ROE: 8.6%
- • ROCE: 8.2%
- • Price vs SMA200: below
- • Golden cross setup: SMA50 below SMA200
Bull case
- • Revenue growth: 98.7% YoY
- • Profit growth: 2463.6% YoY
- • Debt/Equity: 0.28
- • RSI: 61
Bear case
- • ROE: 8.6%
- • ROCE: 8.2%
- • Price vs SMA200: below
- • Golden cross setup: SMA50 below SMA200
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • ROE: 8.6%
- • ROCE: 8.2%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹1.76). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.